Flagship-Backed Empress Therapeutics Launches to Accelerate Small Molecule Development
The startup launches with $50 million to improve its Chemilogics platform, which is designed to speed up the identification and development of small molecule drug candidates.
Flagship-Backed Empress Therapeutics Launches to Accelerate Small Molecule Development Read More »
